Evidence map›Paper›PMID 40456937›Full record

ArticleBone marrow transplantation2025

Outcomes of allogeneic stem cell transplant in adult Philadelphia negative acute lymphoblastic leukemia patients treated with the pediatric-inspired GIMEMA 1913 protocol. A Campus ALL study.

Gianluca Cavallaro, Davide Lazzarotto, Chiara Pavoni, Francesca Valsecchi, Anna Grassi, Cristina Papayannidis, Marco Cerrano, Nicola Fracchiolla, Fabio Giglio, Michelina Dargenio and 31 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

41 authors.

Gianluca CavallaroHematology and Bone Marrow Transplant Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.ORCID 0009-0003-0507-8384
Davide LazzarottoClinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
Chiara PavoniHematology and Bone Marrow Transplant Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Francesca ValsecchiHematology and Bone Marrow Transplant Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Anna GrassiHematology and Bone Marrow Transplant Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Cristina PapayannidisIRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.
Marco CerranoS.C. Ematologia, AOU Città della Salute e della Scienza - Presidio Molinette, Torino, Italy.
Nicola FracchiollaU.O. Ematologia, IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy.
Fabio GiglioUO Ematologia e Trapianto di Midollo osseo, IRCCS Ospedale San Raffaele, Milano, Italy.ORCID 0000-0003-4755-9533
Michelina DargenioS.C. Ematologia, Ospedale Vito Fazzi, Lecce, Italy.
Monia LunghiUOC Ematologia, Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy.
Silvia ImbergamoEmatologia Azienda Ospedale Università di Padova, Padova, Italy.
Maria Ilaria Del PrincipeDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy.
Silvia TrappoliniS.O.D. Clinica Ematologica, Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I, Ancona, Italy.
Monica FumagalliHematology and Bone Marrow Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Patrizia ZappasodiDivision of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Prassede SalutariUOC Ematologia, Azienda USL di Pescara, Pescara, Italy.
Mario DeliaU.O. Ematologia con Trapianto Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy.
Crescenza PasciollaU.O. di Ematologia, IRCCS Istituto Tumori Giovanni Paolo II, Bari, Italy.
Federico MosnaHematology and Bone Marrow Transplantation Unit, Hospital of Bolzano (SABES-ASDAA), Teaching Hospital of Paracelsus Medical University (PMU), Bolzano, Italy.
Barbara ScappiniSODc Ematologia, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
Fabio ForghieriClinica Ematologica, Azienda Ospedaliero Universitaria di Modena e Dipartimento di Scienze Mediche e Chirurgiche, UNIMORE, Modena, Italy.
Patrizia ChiusoloDipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.ORCID 0000-0002-1355-1587
Cristina SkertUOC Ematologia, Azienda Ulss3 Serenissima, Ospedale dell'Angelo, Venezia, Italy.
Benedetta CambòHematology and BMT Unit, Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy.
Marzia DefinaUOC Ematologia, Azienda Ospedaliero Universitaria Senese, Siena, Italy.
Giuseppe LanzaroneS.C. Ematologia U, Department of Oncology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
Endri MauroUOC Ematologia, Ospedale Cà Foncello, Treviso, Italy.
Massimiliano BonifacioDepartment of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area - University of Verona, Verona, Italy.ORCID 0000-0003-0716-1686
Carla MazzoneHaematology, Department of Medical Area, St. Eugenio Hospital, Roma, Italy.
Lidia SantoroU.O.C. Ematologia e Trapianto di Midollo Osseo, Avellino, Italy.
Antonino MulèU.O.C. di Oncoematologia AO Villa Sofia-Cervello, Palermo, Italy.
Valentina ManciniUO Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Paola MinettoClinica Ematologica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Giorgia BattipagliaDipartimento di Medicina Clinica e Chirurgia, AOU Federico II, Napoli, Italy.ORCID 0000-0002-0695-3879
Alessandro CignettiSCDU Ematologia Azienda Ospedaliera Ordine Mauriziano, Torino, Italy.
Lara AprileUO Ematologia, Ospedale San Giuseppe Moscati, Taranto, Italy.
Sabina ChiarettiEmatologia, Dipartimento di Medicina Traslazionale e di Precisione, "Sapienza" Università di Roma, Rome, Italy.
Robin FoàEmatologia, Dipartimento di Medicina Traslazionale e di Precisione, "Sapienza" Università di Roma, Rome, Italy.ORCID 0000-0002-5021-3026
Anna CandoniClinica Ematologica - Centro Trapianti e Terapie Cellulari, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.ORCID 0000-0003-4436-1310
Federico LussanaHematology and Bone Marrow Transplant Unit, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy. flussana@asst-pg23.it.ORCID 0000-0002-6510-8616

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allogeneic hematopoietic stem cell transplantation (alloHSCT) is the best consolidative treatment for high-risk acute lymphoblastic leukemia (ALL). The Campus ALL study group analyzed the clinical outcomes of patients treated in the real-life with the pediatric-inspired and minimal/measurable residual disease (MRD)-oriented GIMEMA LAL1913 protocol who underwent alloHSCT. Key factors impacting on outcomes were MRD and remission status (1

Indexed as

Hematopoietic Stem Cell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, HomologousAdolescentAdultAgedDisease-Free SurvivalFemaleHumansMaleMiddle AgedNeoplasm, ResidualSurvival RateTreatment OutcomeYoung Adult

Identifiers

PMID40456937
PMCPMC12401717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.